R&D

GSK ESMO
Biotech

GSK says 'stay tuned' for more ADC data as Hansoh posts 49% ORR

GSK may be happy with the latest Hansoh readouts, but the Big Pharma’s oncology R&D chief told Fierce to “stay tuned” for the company’s own data.
James Waldron Oct 19, 2025 10:40am
Wood shavings and chisels on a workbench

Takeda turns to AI drug designer after whittling down R&D focus

Oct 14, 2025 5:00am
Toronto

Sanofi inks pact with Canadian tech company to bring AI to R&D

Oct 8, 2025 12:13pm
Red boxing gloves

Takeda lays off 137 US staff as part of cell therapy retreat

Oct 1, 2025 3:13pm
denovirus transmission replication treatments 3D scientific illustration

Biogen discontinues all AAV gene therapy work

Sep 26, 2025 11:04am
GSK
Favicon Fierce Pharma

GSK plots $30B investment in US manufacturing, R&D

Sep 16, 2025 7:01pm